MedTrace Logo

Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial

NCT07145307 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-04-28

No results posted yet for this study

Summary

The goal of this feasibility study is to test whether a new blended digital intervention for adolescents with anxiety disorders is feasible and acceptable for use, and to help plan future larger scale studies. The main questions it aims to answer are:

* A: Can the investigators recruit appropriate participants?
* B: How appropriate are the data collection procedures and outcome measures?
* C: Are the study procedures and interventions suitable for and acceptable to the participants?
* D: Does the research team have the resources and ability to manage the study and intervention?
* E: Does the intervention show promise of being successful for adolescents with anxiety disorders?

Participants will:

* Receive outpatient anxiety treatment, typically every other week or weekly.
* Use the Sidekick app as a homework supplement to plan, carry out, and evaluate exposure exercises between treatment sessions.
* Complete questionnaires before, during, after, and three months after using the app.
* Some participants and therapists will be invited to take part in qualitative interviews following the intervention.

Conditions

Interventions

DEVICE

Sidekick

An app for adolescents used to plan, complete and evaluate exposure exercises completed between sessions at a children and adolescent mental health clinic (BUP)

Sponsors & Collaborators

  • Alcohol and Drug Research Western Norway (KoRFor)

    collaborator UNKNOWN

  • Research Centre for Digital Mental Health Services (Forhelse)

    collaborator UNKNOWN

  • Helse Stavanger HF

    lead OTHER_GOV

Principal Investigators

  • Aleksander H Erga, PhD · KORFOR, Helse Stavanger

  • Torgeir G Lid, PhD · KORFOR, Helse Stavanger

  • Emilie S Nordby, PhD · Forhelse, Helse Bergen

  • Tine Nordgreen, PhD · Forhelse, Helse Bergen

  • Pia R Hauge, Master · Helse Stavanger HF

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-20
Primary Completion
2026-10-31
Completion
2027-03-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07145307 on ClinicalTrials.gov